Cocrystal Pharma (COCP) Earnings Analysis
Cocrystal Pharma (COCP) next reports earnings on 2026-08-13, consensus EPS -0.17 USD. Last quarter (2026-05-21) it missed with EPS -0.16 USD vs -0.15 USD est (-6.7%). It has beaten estimates in 4/7 recent quarters (57%). Trailing P/E -1.27.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does COCP next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | -0.17 USD |
| Revenue estimate | 0.00B |
COCP earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-21 | -0.16 USD | -0.15 USD | -6.7% | Miss |
| 2026-05-15 | -0.17 USD | -0.15 USD | -13.3% | Miss |
| 2025-11-14 | -0.19 USD | -0.22 USD | +13.6% | Beat |
| 2025-08-14 | -0.2 USD | -0.3 USD | +33.3% | Beat |
| 2025-05-15 | -0.23 USD | -0.52 USD | +55.8% | Beat |
| 2025-03-31 | -0.32 USD | -0.55 USD | +41.8% | Beat |
| 2024-08-14 | -0.53 USD | -0.51 USD | -3.9% | Miss |
Beat rate: 4/7 (57%) over reported quarters with consensus data.
COCP valuation and analyst view
| Trailing P/E | -1.27 |
|---|---|
| Trailing EPS | -0.64043 USD |
| Price / book | 3.14 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
| Analyst consensus | Buy (1 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Cocrystal Pharma (COCP)'s next earnings date?
Cocrystal Pharma is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.17 USD and revenue estimate of 0.00B.
Did COCP beat earnings last quarter?
In its 2026-05-21 report, COCP posted EPS of -0.16 USD versus a -0.15 USD estimate — a miss of 6.7%.
What is COCP's earnings track record?
Over the last 7 reported quarters with consensus data, COCP beat estimates 4 times (57%).
What is COCP's current P/E ratio and EPS?
COCP trades at a trailing P/E of -1.27 on trailing EPS of -0.6404323226461628 USD.
What do analysts rate COCP?
Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell).